COPD Dashboard

Chronic Obstructive Pulmonary Disease Primary Care Trust Summary: NHS Leeds

Chronic Obstructive Pulmonary Disease (COPD) describes a group of conditions which include emphysema and chronic bronchitis. 100,000 people in Yorkshire and the Humber, or 1.9% of the population, are diagnosed with COPD. However, there are an estimated 177,000 people with COPD, suggesting that 43% of people with the disease are not currently diagnosed. COPD is the fifth largest killer disease in England. In Yorkshire and the Humber more people die from COPD (31.1 per 100,000) than from colorectal cancer (17.4 per 100,000) or chronic liver disease (10.4 per 100,000). A progressive illness, COPD is disabling and the number of people dying as a result of COPD increases with age. The direct cost of COPD to the health system in Yorkshire and the Humber is £77m: or an average of £5m a year for every PCT. The broader economic cost of COPD has been put at £3.8 billion for lost productivity in the UK economy as a whole. 25% of people with COPD are prevented from working due to the disease with at least 20 million lost working days a year among men and 3.5 million lost days among women every year.

A recent national audit showed that readmission rates in Yorkshire were 32% and that the average length of stay a day longer than the national average (Yorkshire 6 days, England 5 days).

The information below summarises key indicators relating to the prevalence, care and outcomes for people with Chronic Obstructive Pulmonary Disease (COPD) within NHS Leeds PCT. Each section of the report is designed to broadly follow a COPD clinical pathway. This information is designed to allow the identification of differences in service provision and the potentially related variation seen at primary care/ provider trust level in outcomes and service usage for those with COPD. It is hoped that this information will generate discussion as to the drivers of any variation reported and encourage identification and adoption of best practice. Many indicators provide links to more detailed sources of information which the user can follow in order to investigate both local and national comparisons A summary of key indicators across the Yorkshire and Humber region is available to accompany the profiles available for each Primary Care Trust.

Identification & Finding the Missing Millions

Chart 1: Prevalence of COPD, all ages, 2009-10 Chart 1a: Prevalence of COPD, all ages, 2006-07 to 2009-10

2.0% 2.0%

1.8% 1.8%

1.6% 1.6%

1.4% 1.4%

1.2% 1.2%

% Prevalence% 1.0% 1.0% 1.9% % Prevalence% 1.7% 0.8% 1.6% 0.8%

0.6%0.6% 0.6%0.6%

0.4% 0.4%

0.2% 0.2%

0.0% 0.0% NHS Leeds Y&H SHA England 2006-07 2007-08 2008-09 2009-10

NHS Leeds Y&H SHA England

Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights reserved reserved Charts 1 & 1a: Quality and Outcomes Framework (QOF) data records the number of patients known to primary care services with COPD. This data has been obtained from The Information Centre for Health and Social Care from the link below http://www.ic.nhs.uk/qof

Chart 2: Prevalence of COPD in those aged 16+ and the estimated additional undiagnosed prevalence, 2009-10 The recorded prevalance of COPD as a proportion of the total population in NHS 5.0% Leeds on the QOF register is 1.7% (13,574 people). This is lower than the regional average of 1.9%. The 13,574 people is equivalent to 2.1% of the population who are 4.5% aged 16+. It is estimated that there are an additional 2.4% (15,430 people) aged over 16 who are undiagnosed with COPD. 4.0%

3.5% 2.4% 1.8% The predicted prevalance of COPD (both diagnosed and undiagnosed) in those 3.0% 1.7% aged over 16 in NHS Leeds is modelled to rise to 4.5% by 2020, an increase of 3,584 cases. 2.5% % COPD Prevalence COPD % 2.0%

1.5% 2.4% 1.0% 2.1% 2.0%

0.5%

0.0% NHS Leeds Y&H SHA England Chart 2: QOF prevalence estimated as a percentage of 16+ population with future projections of the prevalence of COPD including undiagnosed cases for those aged 16+, produced by Eastern Region Public Health Observatory. This work is based on 2005 Estimated 16+ Diagnosed Prevalance Estimated Undiagnosed Prevalence ONS populations and Health survey for England smoking prevalence rates for 2003-05. For a fuller methodology see Prevalence: Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights reserved. Estimated Undiagnosed Prevalence: Eastern Region Public Health Observatory http://www.erpho.org.uk/viewResource.aspx?id=18025

July 2011 Prevention

Chart 3: Smoking prevalence, 2009-10 Chart 4: Proportion of those setting a quit date, who are successful and who are verified as successful, 2009-10

25% 70%

24% 60% 24%

23% 50%

23% 40%

22%

% Successful% 66.4% % Smoking % Prevalence 30% 22% 24.1% 55.1% 52.7% 49.4% 23.3% 21% 20% 38.9% 33.9% 21% 10% 20% 21.0%

20% 0% Smoking Cessation - Proportion of Sucessful Smoking Cessation - Proportion of Varified Quitters Sucessful Quitters 19% NHS Leeds Y&H SHA England

NHS Leeds Y&H SHA England

Source: Yorkshire & Humber Public Health Observatory Source: Lifestyle Statistics; The NHS Information Centre for Health and Social Care Copyright © 2010. The Health and Social Care Information Centre, Lifestyles Statistics. All rights reserved.

Smoking prevalence as reported in the Integrated Household Survey for NHS Leeds Chart 4: From NHS Stop Smoking Service, the proportion of those who set a quite date is 24.1%, which is higher than the regional average. The number of people within during 2009-10 who are recorded as quitting successfully and the proportion who are NHS Leeds who set a quit date with NHS Stop Smoking Services during 2009-10 verified as quitting by CO2 validation. The statistics are available from the Information was 6,641. Centre for Health and Social Care on the link below:

Chart 3: Prevalence of smoking as reported in the Integrated Household Survey, this information is sourced from a Yorkshire and Humber Public Health Observatory report http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles/nhs-stop-smoking- and based on Office of National Statistics surveys services/statistics-on-nhs-stop-smoking-services-england-april-2009--march-2010 http://www.yhpho.org.uk/resource/item.aspx?RID=92561

Provision of High Quality Care and Support

Table 1: Responses from the Yorkshire and the Humber SHA COPD Resources Questionnaire

Table 1: Is a summary of responses from the Is there an agreed care pathway for managing across your Primary Care Organisation recently undertaken Yorkshire and Humber SHA Yes (PCO)? COPD Resource Questionnaire and highlights responses to questions about the provision of services (see Table 2 for information on the utilisation of these service) Is a community pulmonary rehabilitation programme currently provided within your Yes PCO?

Do COPD patients within your PCO currently have access to an early discharge Yes scheme?

Do COPD patients within your PCO currently have access to an admissions avoidance Yes scheme?

Do you have access to an oxygen assessment service for Long Term Assessment Yes Oxygen Therapy (LTOT)?

Do you have access to an oxygen assessment service for ambulatory oxygen? No

Do you have access to an oxygen assessment service for short burst oxygen therapy/ No intermittent oxygen therapy??

Are there formal arrangements for patients with COPD to receive palliative care in your No area?

July 2011 Use of High Quality Care and Support Services

Chart 5: Admissions for COPD per 1,000 people on the COPD QOF Chart 5a: Admissions for COPD per 1,000 population, 2005-06 to register, 2009-10 2009-10

134 3.5

132 3.0

130 2.5

128 2.0

126 Admissions PerAdmissions 1,000 Admissions PerAdmissions 1,000 131.9 1.5 130.6 124

1.0

122

123.1 0.5 120

0.0 118 2005-06 2006-07 2007-08 2008-09 2009-10 NHS Leeds Y&H SHA England NHS Leeds Y&H SHA England

Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights reserved Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights reserved

In 2009-10 there were 1,790 admissions for COPD in NHS Leeds (131.9 admissions per 1,000 people with COPD). The total admissions equate to a PbR tariff of £3.9 million for 2009-10 (or £290,043 per 1,000 people with COPD).

Chart 5: Total admissions in 2009-10 per 1,000 people on the QOF COPD patient Chart 5a: Total admissions in 2005-06 to 2009-10 per 1,000 population, taken from NHS register, taken from NHS Comparators, for admissions which are for ICD-10 codes Comparators, for admissions which are for spells in hospital under the programme between J40-J44, which are ordinary admissions or day cases. budgeting category for COPD. These include all ordinary admissions and day cases. The denominator here varies from that used in chart 5, in order to negate the effect of a changing COPD QOF register over time.

https://www.nhscomparators.nhs.uk/NHSComparators/Login.aspx https://www.nhscomparators.nhs.uk/NHSComparators/Login.aspx

Chart 6: Standardised average length of stay for patients admitted with Chart 7: Sum of PbR tariffs for admissions for COPD per 1,000 people on COPD, 2006-07 to 2009-10 the COPD QOF register, 2009-10

10 £300,000

9 £295,000

8 £290,000

Number of Nights Number 7 PbR Tariff per 1,000 £285,000 £297,174

6 £280,000 £290,043

£282,055 5 £275,000

4 £270,000 2006-07 2007-08 2008-09 2009-10 NHS Leeds Y&H SHA England

NHS Leeds Y&H SHA England

Chart 6: The average length of inpatient stay for spells in hospital where the programme Chart 7: The sum of PbR tariffs which are for ordinary or day case admissions under budgeting category of the spell was that of COPD (group 11A). Day cases are not programme budgeting category 11A, COPD, per 1,000 people on the QOF COPD included. patient register, taken from NHS Comparators for 2009-10.

https://www.nhscomparators.nhs.uk/NHSComparators/Login.aspx https://www.nhscomparators.nhs.uk/NHSComparators/Login.aspx

July 2011 Chart 8: Emergency readmission rates for those with COPD within 30 Chart 9: Emergency readmission rates for those with COPD within 72 days of a previous admission hours of a previous admission

1 1

1 1 % Emergency% Re-Admissions tbc Emergency% Re-Admissions tbc

0 0

0 0 NHS Leeds Y&H SHA England NHS Leeds Y&H SHA England

Chart 8: Chart 9:

Chart 10: Admissions for COPD by hospital provider trust, Q3 2008/09 Chart 11: Standardised average length of stay for patients admitted with to Q2 2010/11 COPD by hospital provider trust, Q3 2008/09 to Q2 2010/11

600 10

500 8

7 400

300 5 Admissions 4 Number of nights 200 3

2 100

0 0 2010/11 Q1 2010/11 Q2 2010/11 2007/08 Q3 2007/08 Q4 2008/09 Q1 2008/09 Q2 2008/09 Q3 2008/09 Q4 2009/10 Q1 2009/10 Q2 2009/10 Q3 2009/10 Q4 2010/11 Q1 2010/11 Q2 2010/11 2007/08 Q3 2007/08 Q4 2008/09 Q1 2008/09 Q2 2008/09 Q3 2008/09 Q4 2009/10 Q1 2009/10 Q2 2009/10 Q3 2009/10 Q4

Copyright © 2011, Re- Copyright © 2011, Re-used used with the permission Leeds Teaching Hospitals with the permission of The Leeds Teaching Hospitals of The Health and Social Health and Social Care Care Information 4 per. Mov. Avg. (Leeds Teaching Hospitals) Information Centre. All rights 4 per. Mov. Avg. (Leeds Teaching Hospitals) Centre. All rights reserved reserved

Chart 10: The number of admissions for COPD during 2009-10 for the main hospital Chart 11: The standardised average number of nights spent in hospital per COPD provider trusts in the PCT region. Taken from NHS Comparators, provided by the NHS admissions during 2009-10 for the main hospital provider trusts in the PCT region. Information Centre for Health and Social Care. Taken from NHS Comparators, provided by the NHS Information Centre for Health and Social Care.

https://www.nhscomparators.nhs.uk/NHSComparators/Login.aspx https://www.nhscomparators.nhs.uk/NHSComparators/Login.aspx

July 2011 Chart 10: Incidence of ambulance callouts for breathing difficulties by ward of address attended, July 2008 - June 2009 The information presented in Chart 12 has been derived from Yorkshire Ambulance 900 Service data and shows the number of callouts for 'breathing difficulties' by the location of the callout (not necessarily the 800 location of residence). These breathing difficulties may be due to a much wider range 700 of conditions that just COPD but present a useful geographical guide to the pressures on ambulance services . 600 No attempt to standardise the results by the size of the ward have been undertaken as the 500 callouts do not relate to any resident population of the ward. Wards with under 50 callouts in the period Callouts 400 have been omitted for data security.

300

200

100

0 Hill Armley Pudsey Kirkstall Rothwell Horsforth Wetherby Moortown Roundhay Alwoodley Harewood Weetwood Headingley Morley North Morley Morley South City & & Hunslet City Middleton Park Chapel Allerton Otley & Yeadon Otley & Temple Newsam Temple Kippax & Methley Farnley & Wortley & Farnley Gipton & Harehills & Gipton Adel & Wharfedale Beeston & HolbeckBeeston & Calverley & Farsley & Calverley Guiseley & Rawdon Garforth & Swillington & Garforth Killingbeck & & Seacroft Killingbeck Ardsley & RobinHood Bramley & Stanningley Hyde ParkWoodhouse & Cross Gates Cross Gates & Whinmoor Burmantofts & Richmond

Source: Yorkshire Ambulance Service Number of incidents PCT Average

Chart 12: The incidence of ambulance callouts for 'breathing difficulties' by ward of address of callout location, July 2008 to June 2009. Data supplied by Yorkshire Ambulance Service.

Table 2: Responses from the Yorkshire and the Humber SHA COPD Resources Questionnaire: Local Provision and Usage of Services

Service in Place?Number of Places Available Referrals Made During Completed Patients Follow-up Courses 2009-10 During 2009-10 Available

Community Pulmonary Rehabilitation: Yes 600 681 253 Yes

Service in Place? Number of Days the Service Hours of Operation Number of Patients Saved Bed Days in Operates Accepted 2009-10

Early Discharge Schemes: Yes 5 8.30-4.30pm 173 173

Service in Place? Number of Days the Service Number of Patients Number of Admissions Operates Accepted Avoided

Admission Avoidance Schemes: Yes 5

Long Term Assessment Ambulatory Oxygen Short Burst Oxygen Number of Patients on Number of Patients on Oxygen Therapy Service Assessment Service in Therapy/ Intermittent Oxygen Register Oxygen Register as a in Place? Place? Oxygen Therapy Proportion of the Assessment Service in COPD QOF Register Place?

Oxygen Services: Yes No No Unknown N/A

Table 2: Is a summary of responses from the recently undertaken Yorkshire and Humber SHA COPD resource questionnaire and highlights responses to questions about the provision and utilisation of services.

July 2011 Outcomes for those with COPD

Chart 13: Proportion of those on the QOF register who fulfil outcome Chart 14: Proportion of those on the QOF register who fulfil outcome measures 2009-10 measures 2009-10, including exceptions

100% 100%

90% 90%

80% 80%

70% 70% Percentage 60% Percentage 60%

50% 50% 92.7% 92.6% 93.4% 90.3% 91.2% 89.9% 89.8% 89.0% 88.5% 87.8% 88.6% 40% 86.6% 40% 82.3% 80.6% 80.5% 78.8% 78.7% 78.1% 78.0% 77.7% 76.1% 76.0% 74.1% 72.9% 30% 30%

20% 20%

10% 10%

0% 0% COPD 8 COPD 10 COPD 12 COPD 13 COPD 8 COPD 10 COPD 12 COPD 13

NHS Leeds Y&H SHA England NHS Leeds Y&H SHA England

Source: Quality and Outcomes Framework, The Information Centre for Health and Social Care Source: Quality and Outcomes Framework, The Information Centre for Health and Social Care Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights reserved reserved

Chart 15: Exception rates for COPD QOF indicators, 2009-10 Charts 13 & 14: These show the proportion of those on the 2009-10 COPD QOF register who meet the criteria for the four COPD outcome measures detailed below:

25%

COPD 8: The percentage of patients with COPD who have had influenza immunisation in the preceding 1 September to 31 March.

20% COPD 10: The percentage of patients with COPD with a record of FeV1 in the previous 15 months.

The percentage of all patients with COPD diagnosed after 1st April 2008 in Percentage 15% COPD 12: whom the diagnosis has been confirmed by post bronchodilator spirometry.

COPD 13: The percentage of patients with COPD who have had a review, undertaken by a healthcare professional, including an assessment of breathlessness using the MRC 10% dyspnoea score in the preceding 15 months. 20.1% 17.5%

15.8% http://www.ic.nhs.uk/qof 13.1% 12.9% Further information for the percentage of patients who have an FeV1 reading in the last 12.4% 12.2% 11.9% 11.9% 11.8% 5% 11.6% 11.6% 15 months presented by practices within NHS Leeds can be found on the final sheet of this Document. This information is again drawn the the QOF data published by the NHS Information Centre for Health and Social Care, 2009-10.

http://www.ic.nhs.uk/qof 0% COPD 8 COPD 10 COPD 12 COPD 13

NHS Leeds Y&H SHA England

Source: Quality and Outcomes Framework, The Information Centre for Health and Social Care Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights reserved

Chart 15: The percentage of people with COPD who are potentially eligible for inclusion in each of the QOF indicators who have been registered as being 'exceptions', 2009-10.

http://www.ic.nhs.uk/qof

July 2011 Chart 16: COPD mortality rates per 100,000 population, 2002 - 2009 Chart 17: Years of life lost due to COPD in those aged under 75, directly standardised rate per 100,000 population, 2007-09 with 95% confidence limits 40 16

35 14

30 12

25 10

20 8

15 DSR per 100,000 12.7 DSR per 100,000 DSR per 6 11.9 10.5 10 4 5 2 0 2002 2003 2004 2005 2006 2007 2008 2009 0 NHS Leeds Y&H SHA England NHS Leeds Y&H SHA England

Source: National Centre for Health Outcomes Development, the NHS Information Centre for Health and Social Care Source: National Centre for Health Outcomes Development, the NHS Information Centre for Health and Social Care Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights reserved Copyright © 2011, Re-used with the permission of The Health and Social Care Information Centre. All rights reserved

Chart 16: This indicator is the directly standardised COPD mortality rate per 100,000 of Chart 17: Directly age standardised years of life lost due to mortality from bronchitis, the population. The standardisation allows a meaningful comparisons between regions emphysema and other COPD (ICD10 J40-J44) for those aged less than 75 years, with differing age profiles. This information is reproduced from information in the National directly standardised rate per 100,000 population, 2007-09. This information is Clinical and Health Outcomes Knowledge Base maintained by the NHS Information reproduced from information in the National Clinical and Health Outcomes Knowledge Centre for Health and Social Care: Base maintained by the NHS Information Centre for Health and Social Care:

http://www.nchod.nhs.uk/ http://www.nchod.nhs.uk/

Expenditure on those with COPD

Chart 18: Programme budgeting spend on COPD per 100,000, 2009-10 Chart 19: Primary care prescribing spend on antimuscarinic bronchodilators (including combinations), July-Sept 2010 £1.45 £300

£246 £250 £223 £1.40

£200 o

0 population £1.35 lator STAR(09)-PUs 0 £150

£1.42 £1.30 £100 £ million £ million per 100,000 p

£50 £1.25 £1.31 NIC per 1,000 bronchodilator £28 £1.28 £19 £2 £4 £0 Ipratropium Ipratropium & Salbutamol Tiotropium £1.20 NHS Leeds Y&H SHA England NHS Leeds Y&H SHA

Source: Department of Health Source: NHS Prescription Services, NHS Business Services Authority. © NHS Business Services Authority 2011

Chart 20: Average primary care prescribing net ingredient cost per item Chart 18: prescribed Programme budgeting data is collected by the Department of health and includes the majority of spend outside of primary care, grouped by condition. The Department £45 produces a range of tools to allow more detailed analysis of expenditure and its comparisons to outcomes levels, the main tool are listed below: £40 Programme Budgeting Toolkit: £35 PCT Spend and Outcomes Tool (SPOT): Programme Budgeting Atlas: £30 NHS Comparators: These can all be accessed from the DH website: £25 http://www.dh.gov.uk/en/Managingyourorganisation/Financeandplanning/Programmebudgeting/ DH_075743

£20 £40.52 £39.04 £38.79 £37.74 £37.23 £36.33 £15 Charts 19 & 20: These are based on data available from NHS Prescription Services and cover primary Average netAverage ingredient cost per item care prescriptions for July to September 2010. In Chart 19 the use of the STAR PU £10 population allows a meaningful comparison between spend in regions with different demographics. £5 £14.82 £10.81

£10.32 http://www.nhsbsa.nhs.uk/PrescriptionServices/2588.aspx

£0 Ipratropium Ipratropium & Salbutamol Tiotropium

NHS Leeds Y&H SHA England

July 2011 Outcomes for those with COPD

Table 3: 2009-10 Quality and Outcomes Framework percentage of COPD patients with an FEV1 reading in the last 15 months for all practices within NHS Leeds.

Pr Name of Practice Percentage of Practice Registered Percentage on COPD Register Percentage on COPD Register ac Patients who are on the COPD with an FeV1 Reading Including Exceptions with an tic Register (% COPD Prevalence) FeV1 Reading e C od B86CITY VIEW MEDICAL PRACTICE 2.1% 80.1% 70.7% B86DR A C PAUL & PARTNERS 2.6% 96.4% 66.1% B86DR A RAI 0.6% 85.7% 66.7% B86DR ADDLESTONE M B & PARTNERS 1.7% 89.6% 75.4% B86DR ADDLESTONE R I & PARTNERS 2.4% 89.1% 75.2% B86DR ALI S A 2.7% 73.0% 69.2% B86DR ALLMAN I G & PARTNERS 1.0% 89.7% 55.9% B86DR BELDERSON L & PARTNERS 3.0% 91.0% 83.3% B86DR BERRIDGE J M 2.1% 95.1% 91.7% B86DR BHANDARY L V & PARTNERS 1.5% 88.4% 79.2% B86DR BIRKIN A E & PARTNERS 1.2% 93.1% 84.8% B86DR BOONIN A S & PARTNERS 2.6% 85.5% 80.7% B86DR BRADY & PARTNERS 2.0% 88.3% 64.3% B86DR BROOM C & PARTNERS 2.1% 95.7% 86.4% B86DR BURKILL A D & PARTNERS 2.1% 84.6% 81.1% B86DR COHEN A F & PARTNERS 1.2% 98.8% 67.2% B86DR CRYSTAL T L & PARTNERS 2.6% 74.8% 64.7% B86DR DARBYSHIRE & PARTNERS 2.4% 87.3% 60.2% B86DR DAVIS SM & PARTNER 1.8% 91.4% 84.2% B86DR ELLISON C 0.8% 100.0% 91.7% B86DR FELLERMAN S M 1.6% 100.0% 77.9% B86DR FJ LAWRENSON AND PARTNERS 1.2% 86.7% 86.7% B86DR GARRETT C J J & PARTNERS 1.7% 89.7% 73.0% B86DR GERAGHTY P G M & PARTNERS 1.6% 97.4% 70.4% B86DR GREEN A L & PARTNER 3.4% 41.2% 39.6% B86DR GREENWAY J & PARTNERS 0.0% 0.0% B86DR GUCKIAN D M F 3.5% 90.5% 87.7% B86DR GUPTA F 2.2% 98.0% 80.6% Y00DR H U PAI 2.4% 90.0% 84.9% B86DR HALL G I & PARTNERS 1.2% 93.0% 77.9% B86DR HICKS C A & PARTNER 2.1% 95.4% 83.8% B86DR HOUGHTON & PARTNERS 1.6% 92.8% 73.6% B86DR HUNJIN M S 0.4% 84.6% 78.6% B86DR HUNTER C M & PARTNER 0.4% 100.0% 44.4% B86DR ISLIP M R & PARTNERS 1.5% 96.6% 84.5% B86DR IWANTSCHAK & PTRS 2.7% 79.4% 73.7% B86DR IWANTSCHAK A & PARTNERS 2.1% 93.8% 69.2% B86DR J KIRKHAM & PARTNERS 1.7% 70.3% 66.7% B86DR KHAN & PARTNER 5.0% 84.7% 71.3% B86DR KINGHORN S H & PARTNERS 1.7% 95.1% 93.6% B86DR KNIGHT J & PARTNERS 2.3% 76.9% 75.0% B86DR L T BLAKEMORE & PARTNERS 1.6% 87.5% 80.4% B86DR LAWRENCE S L & PARTNERS 1.2% 90.0% 67.2% B86DR LAWTON S L & PARTNER 0.6% 77.5% 68.9% B86DR LEDGER & PARTNERS 1.1% 94.9% 82.9% B86DR LEE AV & PARTNERS 1.8% 77.7% 67.1% B86DR LUND J A & PARTNERS 1.3% 86.8% 73.2% B86DR M E HAQUE 2.3% 66.7% 65.6% B86DR MADDY P J & PARTNERS 1.0% 87.7% 74.6% B86DR MANNING S I & PARTNER 1.7% 86.1% 79.5% B86DR MANUEL J B & PARTNERS 0.7% 92.7% 86.4% B86DR MATE J D & PARTNERS 1.0% 91.7% 77.9% B86DR MATHARU S S 1.8% 90.0% 79.4% B86DR MEHROTRMEHROTRAAPN& P N & PARTNER 13%1.3% 8686.7% 7% 8484.8% 8% B86DR MENON R & PARTNERS 3.1% 96.4% 87.5% B86DR MORRIS M & PARTNERS 3.3% 70.2% 67.9% B86DR MOSSAD M G 1.6% 87.5% 87.5% B86DR NEWBOUND A D & PARTNERS 1.8% 88.1% 74.6% B86DR NICHOLLS J A J 2.9% 99.0% 96.3% B86DR OGDEN L M & PARTNERS 3.2% 99.2% 91.9% B86DR O'SHEA T S & PARTNERS 0.9% 94.2% 78.3% B86DR OTTMAN & PARTNERS 1.5% 64.7% 61.6% B86DR P S LEE & PARTNERS 2.4% 93.0% 87.8% B86DR PEARLMAN A D & PARTNERS 1.9% 92.3% 83.7% B86DR PEARSON R E & PARTNERS 1.8% 92.8% 92.8% B86DR PIERECHOD B A & PARTNERS 2.1% 75.8% 61.6% B86DR PORTER & PARTNERS 1.6% 88.1% 78.0% B86DR POTTS R K & PARTNERS 0.8% 93.9% 86.8% B86DR R J ADAMS & PARTNERS 1.8% 72.8% 68.4% B86DR RICKARDS A F & PARTNERS 1.2% 93.2% 82.0% B86DR ROBINSON A S A & PARTNERS 1.9% 82.6% 79.6% B86DR ROSE D M & PARTNER 1.9% 90.7% 79.6% B86DR ROSS R J & PARTNERS 2.1% 94.6% 88.7% B86DR S M LAYBOURN & PARTNERS 3.3% 77.1% 72.6% B86DR S MANSOOR & PARTNER 1.6% 86.2% 75.8% B86DR S R LIGHTFOOT & PARTNERS 0.9% 92.8% 77.1% B86DR SAFFER C M & PARTNERS 2.6% 85.0% 81.5% B86DR SAMUEL C A & PARTNERS 1.1% 93.2% 76.4% B86DR SHARMA S & PARTNER 1.3% 75.9% 75.9% B86DR SHEVLIN P V & PARTNER 1.7% 100.0% 90.1% B86DR SINGH G P & PARTNER 1.0% 88.9% 76.2% B86DR SINGH H & PARTNER 1.9% 98.6% 76.3% B86DR SOOLTAN A R 2.8% 78.4% 65.9% B86DR SPENCER P & PARTNERS 1.4% 91.2% 86.1% B86DR SRIVASTAVA S K 2.8% 89.7% 85.2% B86DR SWABY M J & PARTNERS 2.0% 91.5% 85.0% B86DR T B PATEL & PARTNERS 1.7% 93.8% 73.2% B86DR T S SHEARD 1.5% 87.9% 77.0% B86DR THOMPSON A J & PARTNERS 1.5% 92.0% 76.7% B86DR TOLLEY J M & PARTNERS 1.6% 85.1% 79.4% B86DR W J EDWARDS & PARTNERS 1.5% 85.7% 66.7% B86DR Y F S WONG 1.2% 85.7% 81.1% B86DR ZK MUNCER & PARTNERS 2.2% 92.4% 70.8% B86DR ZOLTOWSKI J A & PARTNERS 1.3% 91.4% 86.7% B86DRS ALLEN STANLEY & HIDE 1.4% 91.8% 91.8% B86DRS HOLMES & EASTWOOD 2.1% 91.5% 86.4% B86GIBSON LANE PRACTICE 1.6% 89.7% 80.9% B86GRANGE MEDICARE M P S 1.9% 90.2% 75.3% B86GRANGE MEDICARE N C S 1.8% 60.2% 53.0% Y00GRANGE MEDICARE S H P 4.6% 87.3% 76.4% B86GUISELEY & YEADON MEDICAL PRACTICE 1.2% 86.1% 78.4% B86HAREHILLS CORNER SURGERY 0.8% 100.0% 80.0% B86LEIGH VIEW MEDICAL CENTRE 1.4% 79.5% 78.0% B86LINCOLN GREEN MEDICAL CENTRE 4.7% 71.4% 57.6% B86ONE MEDICARE LLP (HILTON ROAD) 0.9% 100.0% 83.3% Y02ONE MEDICARE LLP-P EARNSHAW T LIGHT 0.0% 100.0% 100.0% B86RADSHAN MEDICAL CENTRE 2.0% 97.0% 84.2% Y02SHAKESPEARE MEDICAL PRACTICE 0.9% 100.0% 62.5% B86THE GARDEN SURGERY 3.6% 91.9% 83.8% B86THE NORTH LEEDS MEDICAL PRACTICE 1.0% 83.7% 71.3% B86THE STREET LANE PRACTICE 1.1% 79.5% 68.9% B86THE THAKUR PRACTICE - P J LINDSAY 2.5% 84.7% 49.5% B86YEADON TARN MEDICAL PRACTICE 1.7% 99.0% 89.5%

July 2011